Virology Specimen Collection Comprehensive Study by Application (Diagnostics, Research), End-users (Hospitals & Clinics, Diagnostic Centers, Others), Samples (Blood Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples) Players and Region - Global Market Outlook to 2027

Virology Specimen Collection Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Virology Specimen Collection?
Specimens for virus isolation need to be gathered inside four days after onset of sickness as virus shedding decreases swiftly after that time. With solely an uncommon exception, virus cultures are now not rewarding for specimens accrued greater than 7 days after the onset of illness. Equipment used for the series of specimens ought to be easy and dry. No antiseptic have to be current in the specimen bottle. As some distance as feasible morning specimens are collected. If a way of life specimen is required – use sterile containers, get midstream specimen or catherized specimen in case of urine specimen. It is a foundational precept for any laboratory take a look at manner that the price of the check is compromised or even negated by using the usage of specimens that have no longer been good collected, labelled, treated or saved prior to and at some stage in the checking out process.

The market study is broken down, by Application (Diagnostics and Research) and major geographies with country level break-up.

The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Virology Specimen Collection market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Becton, Dickinson and Company (United States), Quidel Corporation (United States), Thermo Fisher Scientific Inc. (United States), Trinity Biotech (Ireland), Titan Biotech Ltd. (India), Diasorin SA (Italy), Vircell S.L. (Spain), Copan Italia S.P.A (Italy), Puritan Medical Products Co. (United Kingdom) and Hardy Diagnostics (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are BNTX Inc. (Germany), Formlabs (United States), Medline Industries, Inc. (United States) and Laboratory Corporation of America Holdings (United States).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Virology Specimen Collection market by Type, Application and Region.

On the basis of geography, the market of Virology Specimen Collection has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-users, the sub-segment i.e. Hospitals & Clinics will boost the Virology Specimen Collection market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Samples, the sub-segment i.e. Blood Samples will boost the Virology Specimen Collection market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

In 2020, Thermo Fisher Scientific (United States) introduced its collaboration with NanoPin Technologies, Inc. for growing extraordinarily touchy liquid chromatography-mass spectrometry (LC-MS) based totally workflows to enhance the detection technological know-how for blood-based infectious diseases.
Specimens for virus isolation need to be gathered inside four days after onset of sickness as virus shedding decreases unexpectedly after that time. With solely a uncommon exception, virus cultures are now not profitable for specimens accrued extra than 7 days after the onset of illness.

Market Trend
  • Growing Blood Donations
  • Increasing Adoption of NAT Technology

Market Drivers
  • Rising Prevalence of Viral Diseases
  • Emergence of Newer Pathogens
  • Rising Prevalence of Human Papillomavirus

Opportunities
  • Increasing Disposable Incomes
  • Improving Healthcare Infrastructure

Restraints
  • Rise in Expenditure of Virology Specimen Collection Technologies
  • Need for Alternative Technologies for Testing of Virology Samples

Challenges
  • High Cost of Virology Specimen Collection Technologies
  • High Cost of R&D


Key Target Audience
Virology specimen collection product manufacturers and suppliers, Contract Research Organizations, R&D Companies, Biopharmaceutical Companies, Government & Independent Research Laboratories and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Application
  • Diagnostics
  • Research
By End-users
  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

By Samples
  • Blood Samples
  • Nasopharyngeal Samples
  • Throat Samples
  • Oral Samples
  • Other Samples

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Viral Diseases
      • 3.2.2. Emergence of Newer Pathogens
      • 3.2.3. Rising Prevalence of Human Papillomavirus
    • 3.3. Market Challenges
      • 3.3.1. High Cost of Virology Specimen Collection Technologies
      • 3.3.2. High Cost of R&D
    • 3.4. Market Trends
      • 3.4.1. Growing Blood Donations
      • 3.4.2. Increasing Adoption of NAT Technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Virology Specimen Collection, by Application, End-users, Samples and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Virology Specimen Collection (Value)
      • 5.2.1. Global Virology Specimen Collection by: Application (Value)
        • 5.2.1.1. Diagnostics
        • 5.2.1.2. Research
      • 5.2.2. Global Virology Specimen Collection by: End-users (Value)
        • 5.2.2.1. Hospitals & Clinics
        • 5.2.2.2. Diagnostic Centers
        • 5.2.2.3. Others
      • 5.2.3. Global Virology Specimen Collection by: Samples (Value)
        • 5.2.3.1. Blood Samples
        • 5.2.3.2. Nasopharyngeal Samples
        • 5.2.3.3. Throat Samples
        • 5.2.3.4. Oral Samples
        • 5.2.3.5. Other Samples
      • 5.2.4. Global Virology Specimen Collection Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Virology Specimen Collection: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton, Dickinson and Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Quidel Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Thermo Fisher Scientific Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Trinity Biotech (Ireland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Titan Biotech Ltd. (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Diasorin SA (Italy)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Vircell S.L. (Spain)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Copan Italia S.P.A (Italy)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Puritan Medical Products Co. (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Hardy Diagnostics (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Virology Specimen Collection Sale, by Application, End-users, Samples and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Virology Specimen Collection (Value)
      • 7.2.1. Global Virology Specimen Collection by: Application (Value)
        • 7.2.1.1. Diagnostics
        • 7.2.1.2. Research
      • 7.2.2. Global Virology Specimen Collection by: End-users (Value)
        • 7.2.2.1. Hospitals & Clinics
        • 7.2.2.2. Diagnostic Centers
        • 7.2.2.3. Others
      • 7.2.3. Global Virology Specimen Collection by: Samples (Value)
        • 7.2.3.1. Blood Samples
        • 7.2.3.2. Nasopharyngeal Samples
        • 7.2.3.3. Throat Samples
        • 7.2.3.4. Oral Samples
        • 7.2.3.5. Other Samples
      • 7.2.4. Global Virology Specimen Collection Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Virology Specimen Collection: by Application(USD Million)
  • Table 2. Virology Specimen Collection Diagnostics , by Region USD Million (2016-2021)
  • Table 3. Virology Specimen Collection Research , by Region USD Million (2016-2021)
  • Table 4. Virology Specimen Collection: by End-users(USD Million)
  • Table 5. Virology Specimen Collection Hospitals & Clinics , by Region USD Million (2016-2021)
  • Table 6. Virology Specimen Collection Diagnostic Centers , by Region USD Million (2016-2021)
  • Table 7. Virology Specimen Collection Others , by Region USD Million (2016-2021)
  • Table 8. Virology Specimen Collection: by Samples(USD Million)
  • Table 9. Virology Specimen Collection Blood Samples , by Region USD Million (2016-2021)
  • Table 10. Virology Specimen Collection Nasopharyngeal Samples , by Region USD Million (2016-2021)
  • Table 11. Virology Specimen Collection Throat Samples , by Region USD Million (2016-2021)
  • Table 12. Virology Specimen Collection Oral Samples , by Region USD Million (2016-2021)
  • Table 13. Virology Specimen Collection Other Samples , by Region USD Million (2016-2021)
  • Table 14. South America Virology Specimen Collection, by Country USD Million (2016-2021)
  • Table 15. South America Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 16. South America Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 17. South America Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 18. Brazil Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 19. Brazil Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 20. Brazil Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 21. Argentina Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 22. Argentina Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 23. Argentina Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 24. Rest of South America Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 25. Rest of South America Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 26. Rest of South America Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 27. Asia Pacific Virology Specimen Collection, by Country USD Million (2016-2021)
  • Table 28. Asia Pacific Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 29. Asia Pacific Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 30. Asia Pacific Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 31. China Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 32. China Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 33. China Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 34. Japan Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 35. Japan Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 36. Japan Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 37. India Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 38. India Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 39. India Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 40. South Korea Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 41. South Korea Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 42. South Korea Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 43. Taiwan Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 44. Taiwan Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 45. Taiwan Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 46. Australia Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 47. Australia Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 48. Australia Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 49. Rest of Asia-Pacific Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 50. Rest of Asia-Pacific Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 51. Rest of Asia-Pacific Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 52. Europe Virology Specimen Collection, by Country USD Million (2016-2021)
  • Table 53. Europe Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 54. Europe Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 55. Europe Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 56. Germany Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 57. Germany Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 58. Germany Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 59. France Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 60. France Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 61. France Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 62. Italy Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 63. Italy Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 64. Italy Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 65. United Kingdom Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 66. United Kingdom Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 67. United Kingdom Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 68. Netherlands Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 69. Netherlands Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 70. Netherlands Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 71. Rest of Europe Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 72. Rest of Europe Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 73. Rest of Europe Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 74. MEA Virology Specimen Collection, by Country USD Million (2016-2021)
  • Table 75. MEA Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 76. MEA Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 77. MEA Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 78. Middle East Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 79. Middle East Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 80. Middle East Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 81. Africa Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 82. Africa Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 83. Africa Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 84. North America Virology Specimen Collection, by Country USD Million (2016-2021)
  • Table 85. North America Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 86. North America Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 87. North America Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 88. United States Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 89. United States Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 90. United States Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 91. Canada Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 92. Canada Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 93. Canada Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 94. Mexico Virology Specimen Collection, by Application USD Million (2016-2021)
  • Table 95. Mexico Virology Specimen Collection, by End-users USD Million (2016-2021)
  • Table 96. Mexico Virology Specimen Collection, by Samples USD Million (2016-2021)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Virology Specimen Collection: by Application(USD Million)
  • Table 108. Virology Specimen Collection Diagnostics , by Region USD Million (2022-2027)
  • Table 109. Virology Specimen Collection Research , by Region USD Million (2022-2027)
  • Table 110. Virology Specimen Collection: by End-users(USD Million)
  • Table 111. Virology Specimen Collection Hospitals & Clinics , by Region USD Million (2022-2027)
  • Table 112. Virology Specimen Collection Diagnostic Centers , by Region USD Million (2022-2027)
  • Table 113. Virology Specimen Collection Others , by Region USD Million (2022-2027)
  • Table 114. Virology Specimen Collection: by Samples(USD Million)
  • Table 115. Virology Specimen Collection Blood Samples , by Region USD Million (2022-2027)
  • Table 116. Virology Specimen Collection Nasopharyngeal Samples , by Region USD Million (2022-2027)
  • Table 117. Virology Specimen Collection Throat Samples , by Region USD Million (2022-2027)
  • Table 118. Virology Specimen Collection Oral Samples , by Region USD Million (2022-2027)
  • Table 119. Virology Specimen Collection Other Samples , by Region USD Million (2022-2027)
  • Table 120. South America Virology Specimen Collection, by Country USD Million (2022-2027)
  • Table 121. South America Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 122. South America Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 123. South America Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 124. Brazil Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 125. Brazil Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 126. Brazil Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 127. Argentina Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 128. Argentina Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 129. Argentina Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 130. Rest of South America Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 131. Rest of South America Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 132. Rest of South America Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 133. Asia Pacific Virology Specimen Collection, by Country USD Million (2022-2027)
  • Table 134. Asia Pacific Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 135. Asia Pacific Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 136. Asia Pacific Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 137. China Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 138. China Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 139. China Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 140. Japan Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 141. Japan Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 142. Japan Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 143. India Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 144. India Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 145. India Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 146. South Korea Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 147. South Korea Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 148. South Korea Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 149. Taiwan Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 150. Taiwan Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 151. Taiwan Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 152. Australia Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 153. Australia Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 154. Australia Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 155. Rest of Asia-Pacific Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 156. Rest of Asia-Pacific Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 157. Rest of Asia-Pacific Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 158. Europe Virology Specimen Collection, by Country USD Million (2022-2027)
  • Table 159. Europe Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 160. Europe Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 161. Europe Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 162. Germany Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 163. Germany Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 164. Germany Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 165. France Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 166. France Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 167. France Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 168. Italy Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 169. Italy Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 170. Italy Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 171. United Kingdom Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 172. United Kingdom Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 173. United Kingdom Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 174. Netherlands Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 175. Netherlands Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 176. Netherlands Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 177. Rest of Europe Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 178. Rest of Europe Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 179. Rest of Europe Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 180. MEA Virology Specimen Collection, by Country USD Million (2022-2027)
  • Table 181. MEA Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 182. MEA Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 183. MEA Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 184. Middle East Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 185. Middle East Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 186. Middle East Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 187. Africa Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 188. Africa Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 189. Africa Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 190. North America Virology Specimen Collection, by Country USD Million (2022-2027)
  • Table 191. North America Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 192. North America Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 193. North America Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 194. United States Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 195. United States Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 196. United States Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 197. Canada Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 198. Canada Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 199. Canada Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 200. Mexico Virology Specimen Collection, by Application USD Million (2022-2027)
  • Table 201. Mexico Virology Specimen Collection, by End-users USD Million (2022-2027)
  • Table 202. Mexico Virology Specimen Collection, by Samples USD Million (2022-2027)
  • Table 203. Research Programs/Design for This Report
  • Table 204. Key Data Information from Secondary Sources
  • Table 205. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Virology Specimen Collection: by Application USD Million (2016-2021)
  • Figure 5. Global Virology Specimen Collection: by End-users USD Million (2016-2021)
  • Figure 6. Global Virology Specimen Collection: by Samples USD Million (2016-2021)
  • Figure 7. South America Virology Specimen Collection Share (%), by Country
  • Figure 8. Asia Pacific Virology Specimen Collection Share (%), by Country
  • Figure 9. Europe Virology Specimen Collection Share (%), by Country
  • Figure 10. MEA Virology Specimen Collection Share (%), by Country
  • Figure 11. North America Virology Specimen Collection Share (%), by Country
  • Figure 12. Global Virology Specimen Collection share by Players 2021 (%)
  • Figure 13. Global Virology Specimen Collection share by Players (Top 3) 2021(%)
  • Figure 14. Global Virology Specimen Collection share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 17. Becton, Dickinson and Company (United States) Revenue: by Geography 2021
  • Figure 18. Quidel Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 19. Quidel Corporation (United States) Revenue: by Geography 2021
  • Figure 20. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2021
  • Figure 22. Trinity Biotech (Ireland) Revenue, Net Income and Gross profit
  • Figure 23. Trinity Biotech (Ireland) Revenue: by Geography 2021
  • Figure 24. Titan Biotech Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 25. Titan Biotech Ltd. (India) Revenue: by Geography 2021
  • Figure 26. Diasorin SA (Italy) Revenue, Net Income and Gross profit
  • Figure 27. Diasorin SA (Italy) Revenue: by Geography 2021
  • Figure 28. Vircell S.L. (Spain) Revenue, Net Income and Gross profit
  • Figure 29. Vircell S.L. (Spain) Revenue: by Geography 2021
  • Figure 30. Copan Italia S.P.A (Italy) Revenue, Net Income and Gross profit
  • Figure 31. Copan Italia S.P.A (Italy) Revenue: by Geography 2021
  • Figure 32. Puritan Medical Products Co. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 33. Puritan Medical Products Co. (United Kingdom) Revenue: by Geography 2021
  • Figure 34. Hardy Diagnostics (United States) Revenue, Net Income and Gross profit
  • Figure 35. Hardy Diagnostics (United States) Revenue: by Geography 2021
  • Figure 36. Global Virology Specimen Collection: by Application USD Million (2022-2027)
  • Figure 37. Global Virology Specimen Collection: by End-users USD Million (2022-2027)
  • Figure 38. Global Virology Specimen Collection: by Samples USD Million (2022-2027)
  • Figure 39. South America Virology Specimen Collection Share (%), by Country
  • Figure 40. Asia Pacific Virology Specimen Collection Share (%), by Country
  • Figure 41. Europe Virology Specimen Collection Share (%), by Country
  • Figure 42. MEA Virology Specimen Collection Share (%), by Country
  • Figure 43. North America Virology Specimen Collection Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Becton, Dickinson and Company (United States)
  • Quidel Corporation (United States)
  • Thermo Fisher Scientific Inc. (United States)
  • Trinity Biotech (Ireland)
  • Titan Biotech Ltd. (India)
  • Diasorin SA (Italy)
  • Vircell S.L. (Spain)
  • Copan Italia S.P.A (Italy)
  • Puritan Medical Products Co. (United Kingdom)
  • Hardy Diagnostics (United States)
Additional players considered in the study are as follows:
BNTX Inc. (Germany) , Formlabs (United States) , Medline Industries, Inc. (United States) , Laboratory Corporation of America Holdings (United States)
Select User Access Type

Key Highlights of Report


Apr 2022 241 Pages 58 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Becton, Dickinson and Company (United States), Quidel Corporation (United States), Thermo Fisher Scientific Inc. (United States), Trinity Biotech (Ireland), Titan Biotech Ltd. (India), Diasorin SA (Italy), Vircell S.L. (Spain), Copan Italia S.P.A (Italy), Puritan Medical Products Co. (United Kingdom) and Hardy Diagnostics (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
Analysts at AMA estimates Virology Specimen Collection Market to reach USD Million by 2027.

Know More About Global Virology Specimen Collection Market Report?